Stomach cancer

More than 2,200 Australians were diagnosed with stomach cancer in 2020 and 1,140 died from the disease. Sadly, stomach cancer is often not diagnosed until it is at an advanced stage when it is more difficult to treat, and the five-year survival rate of less than 30 per cent.

What is stomach cancer?

Stomach cancer risk factors

Stomach cancer diagnosis

Our stomach cancer research

Late diagnosis is one of the biggest issues in stomach cancer. By uncovering how stomach cancer develops and spreads, our scientists’ goal is to save lives thorough better detection and treatments.

Keeping stomach cancer at bay

Professor Richard Ferrero from the Gastrointestinal Infection and Inflammation Research Group at Hudson InstitutePrevention and molecular studies. Some people with H. pylori infection develop a rare form of cancer, known as MALT lymphoma, in which white blood cells accumulate in the stomach. Professor Ferrero’s group has identified a protein that prevents the accumulation of these cells in the stomach. Ongoing studies are focussed on identifying novel biomarkers and developing new therapies against this cancer.

Lead Researcher | Professor Richard Ferrero

Development of a vaccine against stomach cancer

A new therapeutic target for Helicobacter pylori-induced stomach cancer

Stomach cancer collaborators

Support for people with stomach cancer

Hudson Institute scientists cannot provide medical advice.
Find out more about stomach cancer.

Share this page